9f6c
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Cardiac myosin motor domain in the pre-powerstroke state co-crystallized with the inhibitor aficamten== | |
| - | + | <StructureSection load='9f6c' size='340' side='right'caption='[[9f6c]], [[Resolution|resolution]] 2.33Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[9f6c]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Bos_taurus Bos taurus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=9F6C OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=9F6C FirstGlance]. <br> | |
| - | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.33Å</td></tr> | |
| - | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=9f6c FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=9f6c OCA], [https://pdbe.org/9f6c PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=9f6c RCSB], [https://www.ebi.ac.uk/pdbsum/9f6c PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=9f6c ProSAT]</span></td></tr> |
| - | [[Category: | + | </table> |
| - | [[Category: | + | == Function == |
| - | [[Category: Malik | + | [https://www.uniprot.org/uniprot/MYH7_BOVIN MYH7_BOVIN] Muscle contraction. |
| - | [[Category: | + | __TOC__ |
| - | [[Category: | + | </StructureSection> |
| + | [[Category: Bos taurus]] | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Hartman JJ]] | ||
| + | [[Category: Houdusse A]] | ||
| + | [[Category: Malik FI]] | ||
| + | [[Category: Morgan BP]] | ||
| + | [[Category: Robert-Paganin J]] | ||
Current revision
Cardiac myosin motor domain in the pre-powerstroke state co-crystallized with the inhibitor aficamten
| |||||||||||
